Immunotherapy could be a promising new treatment option for patients with difficult-to-treat depression. This is a key finding from a University of Bristol-led pilot randomised controlled clinical trial, published in JAMA Psychiatry today [20 May].

New research presented today at the American Psychiatric Association's Annual Meeting in San Francisco evaluated how accurately a self-reporting tool predicts difficult-to-treat depression, finding that ...